IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

Indian Pharma Network, New Delhi

Leading Pharmaceutical Distributor & Exporter of Anti-Cancer Medicines, Hepatitis & Specialized Life Saving Drugs. Bringing cure building hope by doing name patient medicine supply for Indian Patients.

Partnering for International Medicines

To Ensure Facilitation of procurement of all Specialty International Medicines unavailable in India at the best price for the patient. We have very good and Strategic agreements with US, UK and European Suppliers to Access to these International Prescription Medicines which can be Import for patients directly.

Bringing Cure………Building Hope

Our Network Helps the Patients/ Physicians/ Hospitals to access and procure these US and European FDA approved Medicines to Indian and other needy patients in Asia.

Cold Chain Management

We take complete arrangements and precautions for proper delivery of cold chain. We ship the imported medicines in a special box in which the cold temperature is maintained during the transit till the patient receives it.

Indian Manufacturer Brands

A wide range of anti-cancer DGCI approved drugs could be found with top pharma manufacturing company in India which deals with the anti-cancer/ oncology drug medicines and product range.

Medical Supplies & Equipment in India

Our products are supplied all over India to government as well as private hospitals, nursing homes and medical colleges.

US FDA / EMA Approved Medicines

To Ensure Facilitation of procurement of all Specialty International Medicines unavailable in India at the best price for the patient.

Indian Manufacturer Medicines

A wide range of anti-cancer DGCI approved drugs could be found with top pharma manufacturing company in India

Medical Tourism / Second Opinion

The most popular treatments sought in India by medical tourists are alternative medicine, bone-marrow transplant, cardiac bypass, eye surgery, and hip replacement.

Medical Supplies & Equipment's

Our products are supplied all over India to government as well as private hospitals, nursing homes and medical colleges.

Indian Pharma Network (IPN)
Leading Pharma Distributor
In the New Delhi.

Getting medicine to patients in need through Patient Name Basis Treatment. Often grouped under the labels of compassionate use, expanded access, or named patient supply, these named patient program is governed by rules which vary by country defining access criteria.

We are associated with top Pharmaceutical Companies of the country. Building long lasting relationships in Pharma Distribution.

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.

Branch Offices in India :

New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur

Oncology Medications List

Anti cancer / Oncology Drug formulations and various other pharma formulations

Brentuximab Vedotin for injection

Hodgkin lymphoma, Systemic anaplastic large cell lymphoma. Approval 2011.

Gilteritinib tablets

Chronic lymphocytic leukemia (CML). Approval 2017.

Mitotane tablets

Cancer in the adrenal glands. Approval 1970.

Alectinib capsules

To treat non-small-cell lung cancer (NSCLC). Approval 2017.

Blinatumomab for injection

B-cell acute lymphoblastic leukemia (B-ALL). Approval 2014.

Bortezomib for Injection

Lymphoma, Multiple Myeloma Approval 2003.

Cobimetinib tablets

For the Treatment of Melanoma . Approval 2015.

Defibrotide sodium for injection

To treat veno-occlusive disease. Approval 2020.

Fam-trastuzumab deruxtecan-nxki for injection

Unresectable or metastatic HER2-positive breast cancer. Approval 2019

Cefiderocol for injection

To treat complicated urinary tract infections . Approval 2011.

Adalimumab Injection

To treat rheumatoid arthritis. Approval 2003.

Ponatinib tablets

Blast phase chronic myeloid leukemia (CML).
Leukemia. Approval 2012.

Trametinib tablet

Mutated metastatic melanoma. Approval 2013.

Nelarabine Injection

T-cell acute lymphoblastic. Approval 2005.

Ixazomib capsules

Multiple Myeloma. Approval: 2015

Polatuzumab vedotin-piiq for injection

Antibody-drug conjugate or ADC designed for the treatment of cancer. Approval 2019.

Dabrafenib capsules

BRAF V600E mutation-positive advanced melanoma. Approval 2013.

Sacituzumab govitecan-hziy for injection

Metastatic triple-negative breast cancer (mTNBC). Approval 2020.

Tucatinib tablets

HER2-positive breast cancer, brain
metastases. Approval: 2020

Venetoclax tablets

Chronic lymphocytic leukemia (CML). Approval 2017.

Daunorubicin and cytarabine liposome injection

Acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC). Approval 2017.

Team Members

Neeraj Nagpal

Neeraj Nagpal

Business Development & Operations

22+ years of experience in pharma sales & marketing. Handles all operations over the country. 

Himanshu Tiwari

Himanshu Tiwari

Sales Coordinator, Mumbai

Serving the patients by dedicatedly working in the pharmaceuticals industry

Testimonials

Dear Mr. Neeraj Nagapal, Indian Pharma Network.
I would like to thank you for your outstanding serive in procuring drug. Vitarvi from InternationalMarket within a short span of time and at very good price.
Your dedication to work will result in increase of your client base. and we expect you to grow in futureif you deliver the same quality of work.

Dr Jayant Mudgal, Delhi

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398